InnoCan Pharma Corporation (CSE:INNO)

InnoCan Pharma Revenue

InnoCan Pharma had revenue of $6.47M USD in the quarter ending March 31, 2026, a decrease of -17.07%. This brings the company's revenue in the last twelve months to $25.28M, down -17.02% year-over-year. In the year 2025, InnoCan Pharma had annual revenue of $26.61M, down -9.60%.

• Revenue (ttm): $25.28M
• Revenue Growth: -17.02%
• P/S Ratio: 0.40
• Revenue / Employee: $5.06M
• Employees: 5
• Market Cap: 14.17M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	26.61M	-2.83M	-9.60%
Dec 31, 2024	29.44M	15.78M	115.55%
Dec 31, 2023	13.66M	11.10M	433.69%
Dec 31, 2022	2.56M	2.36M	1,205.61%
Dec 31, 2021	196.00K	188.00K	2,350.00%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error